21st Century Adult Cancer Sourcebook: Myelodysplastic Syndromes (MDS), Refractory Anemia, Refractory Cytopenia - Clinical Data for Patients, Families, and Physicians

Nonfiction, Health & Well Being, Health, Ailments & Diseases, Cancer
Cover of the book 21st Century Adult Cancer Sourcebook: Myelodysplastic Syndromes (MDS), Refractory Anemia, Refractory Cytopenia - Clinical Data for Patients, Families, and Physicians by Progressive Management, Progressive Management
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Progressive Management ISBN: 9781465711557
Publisher: Progressive Management Publication: October 19, 2011
Imprint: Smashwords Edition Language: English
Author: Progressive Management
ISBN: 9781465711557
Publisher: Progressive Management
Publication: October 19, 2011
Imprint: Smashwords Edition
Language: English

Authoritative information and practical advice from the nation's cancer experts about Myelodysplastic Syndromes (MDS) and refractory anemia includes official medical data on signs, symptoms, early detection, diagnostic testing, risk factors and prevention, treatment options, surgery, radiation, drugs, chemotherapy, staging, biology, prognosis, and survival, with a complete glossary of technical medical terms and current references.

Starting with the basics, and advancing to detailed patient-oriented and physician-quality information, this comprehensive in-depth compilation gives empowered patients, families, caregivers, nurses, and physicians the knowledge they need to understand the diagnosis and treatment of MDS.

Comprehensive data on clinical trials is included - with information on intervention, sponsor, gender, age group, trial phase, number of enrolled patients, funding source, study type, study design, NCT identification number and other IDs, first received date, start date, completion date, primary completion date, last updated date, last verified date, associated acronym, and outcome measures.

Myelodysplastic syndromes are a group of diseases in which the bone marrow does not make enough healthy blood cells. Normally, the bone marrow makes blood stem cells (immature cells) that develop into mature blood cells over time. A blood stem cell may become a myeloid stem cell or a lymphoid stem cell. The lymphoid stem cell develops into a white blood cell. The myeloid stem cell develops into one of three types of mature blood cells: Red blood cells that carry oxygen and other materials to all tissues of the body; white blood cells that fight infection and disease; and platelets that help prevent bleeding by causing blood clots to form.

In myelodysplastic syndromes, the blood stem cells do not mature into healthy red blood cells, white blood cells, or platelets. The immature blood cells, called blasts, do not function normally and either die in the bone marrow or soon after they enter the blood. This leaves less room for healthy white blood cells, red blood cells, and platelets to develop in the bone marrow. When there are fewer blood cells, infection, anemia, or easy bleeding may occur.

There are several types of myelodysplastic syndromes. Myelodysplastic syndromes have too few of one or more types of healthy blood cells in the bone marrow or blood. Myelodysplastic syndromes include the following diseases:

* Refractory anemia.

* Refractory anemia with ringed sideroblasts.

* Refractory anemia with excess blasts.

* Refractory anemia with excess blasts in transformation.

* Refractory cytopenia with multilineage dysplasia.

* Myelodysplastic syndrome associated with an isolated del(5q) chromosome abnormality.

* Unclassifiable myelodysplastic syndrome.

Extensive supplements, with chapters gathered from our Cancer Toolkit series and other reports, cover a broad range of cancer topics useful to cancer patients. This edition includes our exclusive Guide to Leading Medical Websites with updated links to 81 of the best sites for medical information, which let you quickly check for updates from the government and the best commercial portals, news sites, reference/textbook/non-commercial portals, and health organizations. Supplemental coverage includes:

Levels of Evidence for Cancer Treatment Studies
Glossary of Clinical Trial Terms
Clinical Trials Background Information and In-Depth Program
Clinical Trials at NIH
How To Find A Cancer Treatment Trial: A Ten-Step Guide
Taking Part in Cancer Treatment Research Studies
Access to Investigational Drugs
Clinical Trials Conducted by the National Cancer Institute's Center for Cancer Research at the National Institutes of Health Clinical Center
Taking Time: Support for People with Cancer
Facing Forward - Life After Cancer Treatment
Chemotherapy and You

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Authoritative information and practical advice from the nation's cancer experts about Myelodysplastic Syndromes (MDS) and refractory anemia includes official medical data on signs, symptoms, early detection, diagnostic testing, risk factors and prevention, treatment options, surgery, radiation, drugs, chemotherapy, staging, biology, prognosis, and survival, with a complete glossary of technical medical terms and current references.

Starting with the basics, and advancing to detailed patient-oriented and physician-quality information, this comprehensive in-depth compilation gives empowered patients, families, caregivers, nurses, and physicians the knowledge they need to understand the diagnosis and treatment of MDS.

Comprehensive data on clinical trials is included - with information on intervention, sponsor, gender, age group, trial phase, number of enrolled patients, funding source, study type, study design, NCT identification number and other IDs, first received date, start date, completion date, primary completion date, last updated date, last verified date, associated acronym, and outcome measures.

Myelodysplastic syndromes are a group of diseases in which the bone marrow does not make enough healthy blood cells. Normally, the bone marrow makes blood stem cells (immature cells) that develop into mature blood cells over time. A blood stem cell may become a myeloid stem cell or a lymphoid stem cell. The lymphoid stem cell develops into a white blood cell. The myeloid stem cell develops into one of three types of mature blood cells: Red blood cells that carry oxygen and other materials to all tissues of the body; white blood cells that fight infection and disease; and platelets that help prevent bleeding by causing blood clots to form.

In myelodysplastic syndromes, the blood stem cells do not mature into healthy red blood cells, white blood cells, or platelets. The immature blood cells, called blasts, do not function normally and either die in the bone marrow or soon after they enter the blood. This leaves less room for healthy white blood cells, red blood cells, and platelets to develop in the bone marrow. When there are fewer blood cells, infection, anemia, or easy bleeding may occur.

There are several types of myelodysplastic syndromes. Myelodysplastic syndromes have too few of one or more types of healthy blood cells in the bone marrow or blood. Myelodysplastic syndromes include the following diseases:

* Refractory anemia.

* Refractory anemia with ringed sideroblasts.

* Refractory anemia with excess blasts.

* Refractory anemia with excess blasts in transformation.

* Refractory cytopenia with multilineage dysplasia.

* Myelodysplastic syndrome associated with an isolated del(5q) chromosome abnormality.

* Unclassifiable myelodysplastic syndrome.

Extensive supplements, with chapters gathered from our Cancer Toolkit series and other reports, cover a broad range of cancer topics useful to cancer patients. This edition includes our exclusive Guide to Leading Medical Websites with updated links to 81 of the best sites for medical information, which let you quickly check for updates from the government and the best commercial portals, news sites, reference/textbook/non-commercial portals, and health organizations. Supplemental coverage includes:

Levels of Evidence for Cancer Treatment Studies
Glossary of Clinical Trial Terms
Clinical Trials Background Information and In-Depth Program
Clinical Trials at NIH
How To Find A Cancer Treatment Trial: A Ten-Step Guide
Taking Part in Cancer Treatment Research Studies
Access to Investigational Drugs
Clinical Trials Conducted by the National Cancer Institute's Center for Cancer Research at the National Institutes of Health Clinical Center
Taking Time: Support for People with Cancer
Facing Forward - Life After Cancer Treatment
Chemotherapy and You

More books from Progressive Management

Cover of the book Sixteen Cases of Mission Command: Historical Accounts of Battles in American Civil War, Battle of Nile, War of 1812, World War II Europe and Pacific, Corregidor, Sicily, Iraq War, Afghanistan War by Progressive Management
Cover of the book The Quest for Relevant Air Power: Continental European Responses to the Air Power Challenges of the Post-Cold War Era - Allied Air Power and Air Forces, France, Germany, Netherlands, Sweden by Progressive Management
Cover of the book With the 1st Marine Division in Desert Shield and Desert Storm: U.S. Marines in the Persian Gulf, 1990-1991 - Khafji, Weapons Systems, Combat Engineer Breaching Equipment, Training with Saudi Army by Progressive Management
Cover of the book Hearts and Minds: Historical Counterinsurgency (COIN) Lessons to Guide the War of Ideas in the Global War on Terrorism - Insurgents, Historical Case Studies, Malaya Emergency 1945-60, Vietnam War by Progressive Management
Cover of the book Apollo and America's Moon Landing Program: Apollo 17 Technical Crew Debriefing with Unique Observations about the Final Lunar Mission - Astronauts Cernan, Schmitt, and Evans by Progressive Management
Cover of the book "Good Tuberculosis Men": The Army Medical Department's Struggle with Tuberculosis (TB) - Mycobacterium, Tubercular Troops, World War I and II, Heliotherapy, Hospitals, Antibiotics and Streptomycin by Progressive Management
Cover of the book Aghas, Sheiks, and Daesh in Iraq: Kurdish Robust Action in Turmoil - ISIS, ISIL, Islamic State, Iraqi Kurdistan, Special Operations Forces (SOF), Special Operations Command Central (SOCCENT) by Progressive Management
Cover of the book Additive Manufacturing: Preparing for the Reality of Science Fiction, Emerging Technologies and Homeland Security Public Policy, 3D Printers and Autonomous Vehicles, Unmanned Aerial Systems, Drones by Progressive Management
Cover of the book Reading the Enemy's Mail: Origins and Development of U.S. Army Tactical Radio Intelligence in World War II, European Theater of Operations - Wartime Operations, Direction Finding Equipment by Progressive Management
Cover of the book Interagency Standards for Fire and Fire Aviation Operations: Federal Wildland Fire Management Policy, Safety, Risk Management, Chemicals and Delivery Systems, Firefighting Training and Equipment by Progressive Management
Cover of the book 21st Century FEMA Study Course: Emergency Support Function #9 Search and Rescue (IS-809) - Search and Rescue (SAR), Urban (US+R), Coast Guard, Structural Collapse by Progressive Management
Cover of the book NASA's Constellation Program: Lessons Learned (Volume I and II) - Moon and Mars Exploration Program - Ares Rockets and Orion Spacecraft by Progressive Management
Cover of the book Marshall Center Reports: North Korea and Iran's Nuclear Programs as Instability Factors, How Iran Would Apply its Asymmetric Naval Warfare Doctrine in a Future Conflict - Hormuz Chokepoint by Progressive Management
Cover of the book U.S. Special Operations Command Factbook 2012 (USSOCOM) - Aircraft, Weapons, Maritime and Ground Inventory, SOF Truths, Acronyms by Progressive Management
Cover of the book Zika Virus: Examining the U.S. Public Health Response, Coordination of a Multi-Agency Response, Global Zika Epidemic, Mosquito-borne Pathogen, Microcephaly Congenital Birth Defect, Vaccine Development by Progressive Management
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy